Work

Abstract B005: Preliminary safety, PK and efficacy of a PARP1 selective inhibitor VB15010 in patients with advanced solid tumors in phase 1/2 study

Year: 2025

Type: conference-abstract

Source: Molecular Cancer Therapeutics

DOI: 10.1158/1535-7163.targ-25-b005

Authors: Jinming Yu, Yuping Sun, Tiejun Yang, Li Wang, Ruifang An, Jin Yang, Yefeng Lu, Jia Song, Jing Han, Chenxi Li, Douglas Fang, Charles Z. Ding

Institutions: Shandong Tumor Hospital, Henan Cancer Hospital, First Affiliated Hospital of Xi'an Jiaotong University

Language: English

Topic: PARP inhibition in cancer therapy

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4415444541

Cites:

Cited by:

Related to: